Lo Andrew
- SEC CIK
- 0001679076
In the past year, 1 open-market sale filing worth $6.32M and no purchases.
Current role at each company
- BBIO BridgeBio Pharma, Inc.Directoras of Jun 24, 2026
- ABCL AbCellera Biologics Inc.Directoras of Jun 16, 2025
- ROIV Roivant Sciences Ltd.Directoras of Sep 19, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $6.32M
- 1 filing
- Net
- −$6.32M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lo Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BBIO BridgeBio Pharma, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 (view filing) | Dec 29-30, 2021 | 5 days | Lo AndrewDirector | PPurchase | +7.50K | $13.18 | +$98.8K | +18.5%48.1K after | 2 lots |
| May 6, 2025 (view filing) | May 2 | 4 days | Lo AndrewDirector | SSale | −100.0K | $38.50 | −$3.85M | −48.6%105.6K after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Lo AndrewDirector | SSale | −40.6K | $66.67 | −$2.71M | −74.2%14.1K after | 2 lots |
| Nov 19, 2025 (view filing) | Nov 18 | 1 day | Lo AndrewDirector | SSale | −55.0K | $65.69 | −$3.61M | −52.1%50.6K after | 2 lots |